- Jue Mar 19, 2009 12:38 am
#120703
Wenas, segun leo en la wikipedia , parece que la patente de propecia no expira hasta el 2013 
Generic versions
Merck's patent on finasteride (for the treatment of BPH) expired on June 19, 2006.[2] Merck was awarded a separate patent for the use of finasteride to treat male pattern baldness. This patent is set to expire in November 2013.[3]
Several companies outside the US currently manufacture generic finasteride and sell it at a significantly lower cost than Merck:
* Ajanta Pharma (trade name Appecia)
* Aleppo Pharmaceutical (trade name Prosteride)
* Cipla (trade names Fincar and Finpecia)
* Dr. Reddy's (trade names Finax and Finast),
* Intas Pharmaceuticals (trade name Finalo)
* Ranbaxy (trade name Finara)
estoy en lo cierto? mi ingles es muy malo, un saludo.
Generic versions
Merck's patent on finasteride (for the treatment of BPH) expired on June 19, 2006.[2] Merck was awarded a separate patent for the use of finasteride to treat male pattern baldness. This patent is set to expire in November 2013.[3]
Several companies outside the US currently manufacture generic finasteride and sell it at a significantly lower cost than Merck:
* Ajanta Pharma (trade name Appecia)
* Aleppo Pharmaceutical (trade name Prosteride)
* Cipla (trade names Fincar and Finpecia)
* Dr. Reddy's (trade names Finax and Finast),
* Intas Pharmaceuticals (trade name Finalo)
* Ranbaxy (trade name Finara)
estoy en lo cierto? mi ingles es muy malo, un saludo.
